Alzheimer’s-focused Peninsula biotech raises $100M


The company in May said it had completed recruitment of 140 mild to severe Alzheimer's patients for a mid-stage clinical trial.

Previous CalPERS sells 12% of its private equity holdings to reinvest
Next VSP consolidating lens manufacturing, closing six labs nationwide